mebendazole has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smedts Walters, H | 1 |
| Bader-Meunier, B | 1 |
| Dommergues, JP | 1 |
1 other study available for mebendazole and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
-Hemophagocytic syndrome associated with strongyloidiasis in a child treated for acute lymphoblastic leukemia.
Topics: Antinematodal Agents; Antineoplastic Combined Chemotherapy Protocols; Antitrichomonal Agents; Child; | 1998 |